GlassScriptPhysician profile
Lindee R Ledbetter
NPI 1417197682
$9,560.03
in general payments reported to CMS, 2019-2025
20 companies · $746 in 2025
The $746 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,504 · 2022: $5,319 · 2023: $1,289 · 2024: $701 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,736.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,562.77 | 2021-2025 | Aveir, Ensite, Jot Dx |
| Medtronic, INC. | $1,782.21 | 2022 | |
| Atricure, INC. | $1,476.26 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $143.86 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.44 | 2021-2025 | Lifevest |
| Amgen INC. | $59.92 | 2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $59.24 | 2023 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $56.83 | 2021-2022 | |
| Boston Scientific Corporation | $48.26 | 2022-2023 | Avvigo Guidance System |
| E.R. Squibb & Sons, L.L.C. | $47.76 | 2023-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $42.56 | 2022-2023 | Verquvo |
| Astellas Pharma US INC | $39.01 | 2021 | |
| Surmodics, INC. | $31.32 | 2023 | Pounce Thrombectomy, Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Novartis Pharmaceuticals Corporation | $28.02 | 2023 | |
| Davol INC. | $20.16 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.15 | 2021 | |
| Esperion Therapeutics, INC. | $16.89 | 2021 | |
| Novo Nordisk INC | $16.76 | 2023 | Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $16.06 | 2021 | |
| Teleflex LLC | $13.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindee Ledbetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.